Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve Standalone and Consolidated ....
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has informed the exchanges that its Board of Directors will meet on Thursday, August 14, 2025, in New Delhi to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter ended June 30, 2025 (Q1 FY26). The meeting notice will also be uploaded on the company's website as required under SEBI LODR regulations. Additionally, the trading window for designated persons remains closed until August 16, 2025, in line with insider trading rules. No financial figures or outcomes have been disclosed at this stage — this is a routine advance intimation ahead of the results announcement.
This is a standard pre-results filing with no impact on the stock price. Investors should watch the August 14 announcement for actual Q1 FY26 numbers, which could move the stock depending on performance versus expectations.